LFVN

LifeVantage Corporation

Price

$6.24

return (12m)

-41.99%

p/e

15.27

p/bv

2.31

DIVIDEND YIELD

2.98%

LFVN price

LifeVantage

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LFVN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.94%

3 months

4.13%

1 year

-41.99%

2 years

-37.69%

5 years

3.73%

10 years

-29.69%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals LFVN

Valuation

P/E

15.27

Sector -3.53

Industry -3.53

P/BV

2.31

Sector 2.06

Industry 2.06

P/Revenue (PSR)

0.42

Sector 2.02

Industry 2.02

EV/EBITDA

Sector -222.67

Industry -222.67

EV/EBIT

Sector -47.57

Industry -47.57

P/EBITDA

8.73

Sector -21.45

Industry -21.45

P/EBIT

12.70

Sector -28.49

Industry -28.49

P/Total Assets

1.25

Sector 1.20

Industry 1.20

P/Net Current Assets

7.92

Sector -10.32

Industry -10.32

P/Working Capital

4.29

Sector -169.93

Industry -169.93

EPS

0.41

Sector -1.79

Industry -1.79

BVPS

2.69

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

77.56%

Sector 41.30%

Industry 41.30%

EBITDA Margin

5.58%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

3.93%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

3.34%

Sector -35.21%

Industry -35.21%

Net Profit Margins

2.78%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.68

Sector 0.02

Industry 0.02

Profitability

ROE

15.10%

Sector -56.67%

Industry -56.67%

ROA

8.17%

Sector -59.91%

Industry -59.91%

ROIC

16.20%

Sector -2,349.21%

Industry -2,349.21%

Dividends

Dividend yield

2.98%

Sector -

Industry -

Payout

45.50%

Sector -

Industry -

Debt

Current Ratio

1.89

Sector 2.88

Industry 2.88

Net Debt / EBITDA

Sector -14,043,974.86

Industry -14,043,974.86

Net Debt / EBIT

Sector -8.02

Industry -8.02

Net Debt / Equity

Sector -32,936.86

Industry -32,936.86

Gross Debt / Equity

Sector -0.84

Industry -0.84

Equity/Assets

0.54

Sector 0.46

Industry 0.46

Liabilities/Assets

0.46

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-2.92%

Sector -

Industry -

5Y Earnings CAGR

-12.74%

Sector -

Industry -

Fundamentals LFVN

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF LifeVantage ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$6.24

Fair Value

$4.98

Upside

-20.17%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LFVN LifeVantage Corporation	$6.24	-41.99%	2.98%	15.27	2.31	15.10%	2.78%
JNJ Johnson & Johnson	$264.37	51.83%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.50	23.30%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$263.69	24.63%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$42.73	-19.34%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$143.48	80.02%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$163.21	6.36%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.76	44.55%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$73.56	-49.41%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$378.12	40.58%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$779.26	36.63%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$106.73	38.79%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$896.58	26.67%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$514.66	30.45%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$232.56	54.70%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.76	31.52%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$41.09	26.86%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LFVN Historical Dividends

current DY: 2.98%

5-year average DY: 3.74%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/31/2026	09/15/2026	0.05000000
Dividends	05/29/2026	06/15/2026	0.05000000
Dividends	02/27/2026	03/16/2026	0.04500000
Dividends	11/28/2025	12/15/2025	0.04500000
Dividends	09/05/2025	09/16/2025	0.04500000
Dividends	05/29/2025	06/13/2025	0.04500000
Dividends	02/28/2025	03/17/2025	0.04000000
Dividends	11/29/2024	12/16/2024	0.04000000
Dividends	09/06/2024	09/17/2024	0.04000000
Dividends	05/30/2024	06/14/2024	0.04000000
Dividends	02/28/2024	03/15/2024	0.03500000
Dividends	11/29/2023	12/15/2023	0.03500000
Dividends	09/06/2023	09/22/2023	0.43500000
Dividends	05/30/2023	06/15/2023	0.03500000
Dividends	02/27/2023	03/15/2023	0.03000000
Dividends	11/29/2022	12/15/2022	0.03000000
Dividends	08/31/2022	09/15/2022	0.03000000
Dividends	05/13/2022	05/31/2022	0.03000000

ABOUT LifeVantage

LifeVantage Corporation

Average Investor10 user rating

4.0 (4 people)

United States

38 years

Founded: 1988

1997

Time since IPO - 29 years

247

Employees

LifeVantage Corporation (United States) is listed on the Nasdaq and has a market capitalization of $77.47 million, with shareholders equity totaling $33.59 million.

The company employs approximately 247 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, LifeVantage Corporation reported $182.59 million in revenue, generating net income of $5.07 million.

Key financial metrics include a P/E ratio of 15.27, a price-to-book (P/B) ratio of 2.31, and a trailing twelve-month dividend yield of 2.98%.

The company trades under the ticker LFVN.

Market cap

$77.47 million

Net worth

$33.59 million

$33,589,000.00

Assets

$62.11 million

$62,111,000.00

Total Shares Outstanding

12.47 million

12,473,000

Average Daily Trading Volume

$83.25 Thousand

$83,254.00

Sector

Health Care

Industry

Biotechnology

LFVN

LFVN revenue and profits

Financial Results LFVN

DRAG THE FRAME TO SEE MORE DATA

LFVN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$896.58 28,21% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$232.56 56,73% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$264.37 52,40% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$263.69 25,04% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$143.48 83,99% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$163.21 7,03% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.50 22,78% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$896.58 28,21% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$232.56 56,73% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$264.37 52,40% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$263.69 25,04% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$143.48 83,99% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$163.21 7,03% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.50 22,78% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of LifeVantage (LFVN) today?

A cotação de LifeVantage (LFVN) hoje está em US$ 6.24, com uma variação de -41.99% em relação ao último ano. A cotação de LifeVantage (LFVN) iniciou o ano negociando na casa dos US$ 6.16 e hoje está em US$ 6.24. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de LifeVantage (LFVN) e dados de ações do Ibovespa e mercados internacionais.

Quando LifeVantage (LFVN) paga dividendos?

LifeVantage (LFVN) distribuiu dividendos no último ano,in the months of March, June and September totalizando R$ 0.15. O Dividend Yield referente aos 12 últimos meses é de 2.98%.

Is LifeVantage (LFVN) a good investment?

Atualmente, LifeVantage (LFVN) está cotada a US$ 6.24, com um P/L de 15.27, representando um desvio de 570% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -41.99 em sua cotação e distribuiu US$ 0.15 em dividendos, resultando em um Dividend Yield de 2.98%. O retorno total do acionista foi de -41.99%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy LifeVantage (LFVN) stock?

Investir em ações de LifeVantage (LFVN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of LifeVantage (LFVN) yield today?

A rentabilidade de LifeVantage (LFVN) foi de -2.94% no último mês, -41.99% no último ano e 3.73% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.24 em dividendos, um Dividend Yield de 2.98%.

Se você quisesse comprar 100 ações de LifeVantage (LFVN) hoje, o investimento total seria de US$ 624.00, com base na cotação atual de US$ 6.24.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 361.98
Em 5 anos: US$ 647.28
Em 10 anos: US$ 438.73

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LFVN

LifeVantage Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LFVN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING LFVN WITH OTHER STOCK

current DY: 2.98%

5-year average DY: 3.74%

type

Ex - Dividend Date

payment date

value

ABOUT LifeVantage

LifeVantage Corporation

United States

38 years

1997

247

PROFIT X PRICE LFVN

Financial Results LFVN

LFVN cash flow

Asset, Revenue and Profit Growth - LFVN

LFVN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions